Stereotaxis, Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Stereotaxis, Inc. on October 23, 2013. The report addresses a significant regulatory milestone regarding the Company's Niobe Magnetic Navigation System in the Japanese market.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on a regulatory event rather than financial performance data.
Material Changes
- Regulatory Classification: The Ministry of Health, Labor and Welfare in Japan classified the Niobe Magnetic Navigation System as a C2 medical device.
- Reimbursement Status: The C2 classification represents the highest of five reimbursement categories for medical devices in Japan.
Outlook, Risks, and Management Commentary
The filing includes standard forward-looking statements regarding future activities and performance. Management notes that these statements are not guarantees and are subject to risks and uncertainties that could cause actual results to differ materially from projections. The Company states it does not intend to update these statements except as required by law.
Investor Verification Checklist
- Verify the specific reimbursement rates associated with the C2 classification in Japan.
- Confirm the timeline for commercial availability of the Niobe system in Japan following this classification.
- Review the full text of the Press Release (Exhibit 99.1) for additional details on market strategy.
- Assess the potential impact of this classification on the Company's overall revenue projections for the fiscal year.